Sign In
Buy AXGN
$40.63
+1.17 (+2.97%)
At Close: Jun 03, 2026
Analysts' Top Healthcare Picks: Edwards Lifesciences (EW), AxoGen (AXGN)
10:26am, Friday, 24'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Edwards Lifesciences (EW) and AxoGen (AXGN) with bullish
Analysts’ Top Healthcare Picks: Edwards Lifesciences (EW), AxoGen (AXGN)
10:26am, Friday, 24'th Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Edwards Lifesciences (
EW
–
Research Report
) and AxoGen (
AXGN
–
Research Report
) with bullish se
Analysts Offer Insights on Healthcare Companies: AxoGen (AXGN) and Sanofi (OtherSNYNF)
12:35pm, Thursday, 23'rd Apr 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on AxoGen (AXGN) and Sanofi (SNYNF). AxoGen (AXGN) In a report released
Analysts Offer Insights on Healthcare Companies: AxoGen (NASDAQ: AXGN) and Sanofi (Other OTC: SNYNF)
12:35pm, Thursday, 23'rd Apr 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on AxoGen (AXGN – Research Report)
Axogen sees Q1 revenue of ~$24M; class action lawsuit dismissed
12:13pm, Thursday, 23'rd Apr 2020
Axogen (NASDAQ:AXGN) announces preliminary Q1 revenue and a business update in response to the COVID-19 pandemic. Q1 2020 net revenue is estimated to be ~$24.3M (+4% Y/Y). The Company plans to reduce
AxoGen expects pandemic to negatively impact Q2 revenue AXGN
11:35am, Thursday, 23'rd Apr 2020
AxoGen expects pandemic to negatively impact Q2 revenue AXGN
AxoGen lays off approx. 10% of workforce, implements hiring freeze AXGN
11:34am, Thursday, 23'rd Apr 2020
AxoGen lays off approx. 10% of workforce, implements hiring freeze AXGN
AxoGen sees Q1 revenue $24.3M, consensus $27.06M AXGN
11:34am, Thursday, 23'rd Apr 2020
AxoGen sees Q1 revenue $24.3M, consensus $27.06M AXGN
AxoGen announces $7.8M loan under PPP AXGN
11:30am, Thursday, 23'rd Apr 2020
AxoGen announces $7.8M loan under PPP AXGN
Axogen, Inc. (AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced preliminary first quarter 2020 revenue, provided a busines
The CEO of AxoGen (AXGN) is Buying Shares
12:36pm, Monday, 20'th Apr 2020
Today, the CEO of AxoGen (AXGN), Karen Zaderej, bought shares of AXGN for $55.92K. This recent transaction increases Karen Zaderej's holding in the
The CEO of AxoGen (NASDAQ: AXGN) is Buying Shares
12:36pm, Monday, 20'th Apr 2020
Today, the CEO of AxoGen (
AXGN
–
Research Report
),
Karen Zaderej
, bought shares of AXGN for $55.92K.
This recent transaction increases Karen Zaderej’s holding in the company by 1.8% to a total
AxoGen, Inc (NASDAQ:AXGN) Shares Sold by Goldman Sachs Group Inc.
12:32pm, Sunday, 19'th Apr 2020
Goldman Sachs Group Inc. lowered its stake in shares of AxoGen, Inc (NASDAQ:AXGN) by 55.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exc
Companies Like AxoGen (NASDAQ:AXGN) Are In A Position To Invest In Growth
02:42pm, Saturday, 18'th Apr 2020
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
